Tirzepatide

Elevate Your Weight Loss Journey

At Pro Health, we offer compounded tirzepatide injections as part of our comprehensive weight loss program. This weekly treatment combines the benefits of two hormones, GLP-1 and GIP, to effectively regulate appetite and promote a feeling of fullness, leading to reduced calorie intake and significant weight loss.

How Tirzepatide Works

Tirzepatide operates through a dual-action mechanism:

Appetite Suppression:By mimicking GLP-1 and GIP hormones, it reduces hunger signals, helping you feel satisfied with smaller portions.
Slowed Gastric Emptying:It delays stomach emptying, prolonging the sensation of fullness and reducing overall calorie consumption.

This combination not only aids in weight loss but also improves blood sugar control, making it a valuable option for individuals managing type 2 diabetes.

Benefits of Tirzepatide

Clinical studies have demonstrated that tirzepatide can lead to substantial weight loss, often exceeding that achieved with other treatments. Patients have reported:

Significant reductions in body weight
Improved insulin sensitivity
Enhanced metabolic health
Better cardiovascular outcomes

Eligibility Criteria

You may be a candidate for compounded tirzepatide if you:

Have a BMI over 25
Do not have a personal or family history of thyroid cancer
Are not currently on other GLP-1 agonists, diabetic, or thyroid medications
Are not diagnosed with type 1 diabetes
Have no history of suicidal or homicidal ideations

Prior to initiating treatment, we conduct a comprehensive lab panel, including CBC, CMP, blood sugar test, and thyroid screening, to ensure safety and efficacy.

Why Choose Pro Health?

Expert Care: Our Nurse Practitioners specialize in personalized weight loss plans tailored to your unique needs.
Convenience: With five Memphis-area locations, we offer prompt, professional service without the need for appointments.
Comprehensive Support: We provide on-site consultations, lab testing, and medication dispensing for a seamless experience.

1) the compounded tirzepatide drugs are compounded drug products that have not been approved by the FDA; have not been reviewed by the FDA for safety, effectiveness, or quality; and have not been demonstrated to FDA to be safe or effective for their intended use; (2) the processes by which the compounded drugs are manufactured have not been reviewed by the FDA; and (3) FDA-approved products containing tirzepatide are available.